4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ·Healthcare·Biotechnology
$15.39
-3.09%
Mkt Cap $795.64M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (16 analysts)
$33.00
Range $33.00 – $33.00
Implied Upside
+114.4%
Consensus $33.00 vs current $15.39